Amendment in G.S.R. 82 dt. 10.02.2011
Notification - The Drugs and Cosmetics Act, 1940
- Kind: Notification
- Under: The Drugs and Cosmetics Act, 1940
Text of this notification
tfarc# tf o $o -q^o-33004/99 REGD.NO.D.L.-33004/99
9TRcf .^Xl^l Wl
£ke (Basette of ^Jndia
Tf. 283]
No. 283]
EXTRAORDINARY
Wt II—58RW 3-J^-^' , ,5 (')
PART H—Section 3-i-Sub-section(i)
PUBLISHED BY ̂ UmORlTY
^ l ^ f t . ^ W I T ^ I s O ^ O I I / ^ W 9,1933
NEW DELHI, MONDAY, MAY 30, 2011/JYA1STHA 9, 1933
^ftWft, 30^1,2011
l . W , f t 418(3*).—^ TOSflT ̂ 1 3Ttar a*f1q>1
<£ siraR -qr ̂ *PTH "st w «rr % ' ' i m ^TOFT ̂ fan Ufrc
3M«if ^ 3rf*l«P l^iRf foFrT "3TOW11;
afMf ^ faPmH faft t^f fas^r ̂ u f im crnRT 3«I«HW+
3rf*rfWT, 1940 (1940 T̂ 23) ̂ t «IKF 26^ SRI H"W VlPŵ f
3* 3rarr ^ ^ fciPF 10-2-2011 ^t srf^p^n *ram
fasFT î r f̂ cH«l "7* TltMq WITfall;
n>iifrhH" ^m i> #re $ w$ *TT»I ^ r̂c 3 fan*
10-2-2011 ^t <raa 3ifl^^^1^sft3«**iwid*i*Tffe
THtW(fafo?T)U 1054/2011 ^ ^ R f t ^ ^ # 3 k ^ R # T
^wm? ^ wwr 1^gn-î Rf ^ ^RR ^R*SR 3 ̂ F ^ J fan
fig'J|*H ^jfai t*^'-^^m^F^ron,Trcresrfon 3nft
3 f̂#*w ̂ ^t ^ " ^ ̂ r ^IHRI URT ̂ t wi.',
• *R3>R ̂ ^ 1 ^ *TR̂ »̂I t̂TCHR ^ £H fclfc
6-4-2011 ^ « M aUT̂ T 3 TFTHt*? fe# ' 3 ^ -m*H*r1«I ^T
1983 GI/2011 (l>
3RT: 3R HFT-iN ftwft " 3 ^ -^IIIW^ ̂ (^*llFi^i1 ^
smiK m ^ wmi v^m f^#F 10-2-2011 * ^?t
3rftR^T ^T l l i f t 82(3T) ^ ?M % ^ *TC W»T
(ii) 5ftt*F Vim TFT ̂ % ^ 5̂ <WI1 ^
^ f 1gr i im ^ t n ^ %? ^ fe?n?«^e 3|R
%^fei^^RiT3TTT> ncbftd r * ^ - 5 n n # ^ 3 ^ ^ , - ^
^t " ^ ̂ "#, " ^ ^fr * 3fR 3PT WW "^ ̂ ^f I''
[tR f i ^3?T-11014/1/2011-^P^T]
3?^II "qnsi, T̂̂ Ri Hftw
MINISTRY OFHEALTHAND FAMILY WELFARE
(Department of Health and Family Welfare)
NOTIFICATION
New Delhi, the 30thMay, 2011
GS.R, 418(E).—Whereas, the Central Government
was satisfied on the basis of the recommendations of an
expert sub-committee set up by the Drugs Technical
Advisory Board mat use of certain drugs, including the •i*M
drug Human Placental Extract and its formulations for
human use", is likely to involve certain risks to human
beuigs and whereas safer alternatives to the said dmes
are available; ^
Whereas, the Central Government was satisfied that
it is necessary and expedient to prohibit the manufacture,
sale and distribution of the said drugs in public interest
and accordingly in exercise of the powers conferred by
section 26Aofthe Drugs and Cosmetics Act, 1940(23 of
1940) prohibited the manufacture, sale and distribution
of the sad drugs with immediate effect by a notification
No. G.S.R. 82(E) dated 10-2-2011;
Whereas, the said notification dated 10-2-2011 with
respect to its part relating to the drug "Human Placental
Extract and its formulations for human use" was challenged
in Hie H,gh Court ofDelhi in Writ Petition (Civil) No 1054/
2011 and during me deliberations before the Hon'ble Court,
the Government gave an undertaking that the issues
related to safety, efficacy etc. in respect of the drug 'Human
Placental Extract' may be examined by a larger committee;
Whereas, on the undertaking of the Government
the Hon'ble High Court of Delhi in its Order dated
6-4-2011, while disposing off the matter, opined that the
™GAZETTE OFJNDIA: EXTRAORDINARY
[PART fi—SEC. 3(ftl
decision as to whether the ban is to be sustained or lifted
can only be arrived at after the Committee carries out a
comprehensive exercise and submit a report in that regard;
Now, therefore, on the basis of the recommendations
ot the Expert Committee constituted by the Government
as per the directions of the Hon'ble High Court of Delhi
the Central Government hereby amends item No. (4) of the
third paragraph of the aforesaid notification No G SR. 82(E^
dated 10.2.2011 asunder: '
"4. Human Placental Extract and its formulations for
human use except its
(i) Topical application for wound healing, and
(ii) Injection for pelvic inflammatory disease
subject to the condition that the manufacturers of Human
Placental Extract and its formulations for human use shall
maintain meticulous details and traceability of the donors
of the Placenta so as to ensure that the Placenta is collected
from the donors who are free from HIV, HBsAg, HC V and
other viruses."
[F. No. X-11014/1/2011-DFQC]
ARUN K. PANDA, Jt. Secy.
P«»«i*y Ae M a n a g e < ^ r n r a e n l o f i f l d j a Press> R j n g R o a d Mayapuri, New Delh,-! 10064
and RublMed by the Controller of Publications, Delhi-110054.
*